- Pharmaceutical companies
- Europe
- Germany
- Regeneron Pharmaceuticals
Regeneron Pharmaceuticals in Germany
Web: https://www.regeneron.com/
Address:
-
Munich Office
Maximilianstrasse 35, Eingang A Munich, Bayern 80539 Germany
Phone: +49 89 24218000
Other Regeneron Pharmaceuticals's locations around the world
Clinical Trials sponsored by Regeneron Pharmaceuticals
-
Regeneron PharmaceuticalsPas encore de recrutement
-
Regeneron PharmaceuticalsRecrutement
-
Regeneron PharmaceuticalsRecrutementLymphome folliculaire récidivant/réfractaire | Lymphome de la zone marginale (MZL)Corée, République de, Australie, Espagne, Malaisie, France, Taïwan, Italie, Pologne, États-Unis, Thaïlande, Royaume-Uni, Turquie, Belgique, Tchéquie
-
Regeneron PharmaceuticalsRecrutement
-
Regeneron PharmaceuticalsRecrutementSurdité congénitale secondaire à des mutations bialléliques du gène de l'otoferline (OTOF) | Mutations bialléliques dans le gène Gap Junction Beta 2 (GJB2) | Mutations digéniques dans les gènes GJB2/Gap Junction Beta 6 (GJB6)États-Unis
-
Regeneron PharmaceuticalsPas encore de recrutementŒdème maculaire diabétique (OMD) | Dégénérescence maculaire néovasculaire liée à l'âge (nDMA)
-
Regeneron PharmaceuticalsRecrutementLymphome non hodgkinien à cellules B (LNH-B)États-Unis, Royaume-Uni
-
Regeneron PharmaceuticalsRecrutement
-
Regeneron PharmaceuticalsRecrutementStéatohépatite non alcoolique (NASH) | Stéatohépatite associée à un dysfonctionnement métabolique (MASH)États-Unis, Corée, République de, Porto Rico, Japon
-
Regeneron PharmaceuticalsRegeneron PharmaceuticalsRecrutementCancer du poumon non à petites cellulesAllemagne, L'Autriche, France
About Regeneron Pharmaceuticals
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.